25808-30-4 Usage
Description
Methylaminoacetonitrile hydrochloride is a yellow crystalline compound that serves as an essential intermediate in the pharmaceutical and chemical synthesis industries. It is notably recognized as the primary raw material for the preparation of tadalafil, a medication approved by the FDA in 2003 for the treatment of erectile dysfunction in men.
Uses
Used in Pharmaceutical Industry:
Methylaminoacetonitrile hydrochloride is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its primary application is in the production of tadalafil, a drug prescribed for the treatment of erectile dysfunction in men. Tadalafil works by enhancing the effects of nitric oxide in the body, which leads to the widening of blood vessels and improved blood flow to the penis, thus facilitating an erection.
Used in Chemical Synthesis:
In the chemical synthesis industry, methylaminoacetonitrile hydrochloride is utilized as a building block for the creation of various chemical compounds. Its unique structure and properties make it a valuable component in the development of new and innovative products, contributing to the advancement of the chemical synthesis field.
Overall, methylaminoacetonitrile hydrochloride plays a significant role in both the pharmaceutical and chemical synthesis industries, primarily due to its use in the production of tadalafil and its potential applications in the development of new chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 25808-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,8,0 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 25808-30:
(7*2)+(6*5)+(5*8)+(4*0)+(3*8)+(2*3)+(1*0)=114
114 % 10 = 4
So 25808-30-4 is a valid CAS Registry Number.
InChI:InChI=1/C3H6N2.ClH/c1-5-3-2-4;/h5H,3H2,1H3;1H
25808-30-4Relevant articles and documents
METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS
-
, (2008/06/13)
The invention features a method for treating chronic pain using a compound selected from formulae (I), (II)A, (I)B and (I)C.